Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Henley International

This article was originally published in The Gray Sheet

Executive Summary

Firm, which will formally assume the name Maxxim Medical following shareholder approval at the company's March 4 meeting, is offering $50 mil. in convertible subordinated debentures due March 1, 2003. Estimated net proceeds of $47.9 mil. will be used "to finance potential future acquisitions and for general corporate purposes," Henley says in a Feb. 2 registration statement filed with the SEC. The firm notes that "no acquisitions or negotiations for any acquisitions are currently pending." Following the offering, which is being underwritten by Kemper Securities and Morgan Keegan & Company, Henley's long term debt will total $52.7 mil.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000201

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel